New patch aims to speed healing of stubborn diabetic foot sores

NCT ID NCT07209475

Recruiting now Disease control Sponsor: Royal Biologics Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether adding a special patch called Amnio-Maxx to usual wound care helps close chronic diabetic foot ulcers faster than usual care alone. About 248 adults with diabetes and a nonhealing foot ulcer will take part. The main goal is to see if the patch leads to complete wound closure and reduces pain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AMNIO-MAXX are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Diabetic Foot

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AMNIO-MAXX DIABETIC FOOT ULCER (DFU)

Contacts and locations

Locations

Denali Health Atlanta, LLC
RECRUITING

Stone Mountain, Georgia, 30083, United States
Elite Foot & Ankle Associates
RECRUITING

Spicewood, Texas, 78669, United States
Lion Heart Clinical Research
RECRUITING

Burbank, California, 91501, United States
Royal Research South
RECRUITING

Miami, Florida, 33150, United States
SerenaGroup Research Center
RECRUITING

Omaha, Nebraska, 68114, United States
Suffolk Foot and Ankle
RECRUITING

East Patchogue, New York, 11772, United States
VAST Clinical Research Carrollton Foot Center
RECRUITING

Carrollton, Texas, 75010, United States
Wound Care of Tulsa
RECRUITING

Tulsa, Oklahoma, 74135, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.